Theralase Technologies Inc.

OTCPK:TLTF.F Stock Report

Market Cap: US$28.0m

Theralase Technologies Past Earnings Performance

Past criteria checks 0/6

Theralase Technologies has been growing earnings at an average annual rate of 2%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 4.7% per year.

Key information

2.0%

Earnings growth rate

11.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-4.7%
Return on equity-239.9%
Net Margin-427.1%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Theralase Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:TLTF.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231-523
30 Sep 231-423
30 Jun 231-524
31 Mar 231-524
31 Dec 221-524
30 Sep 221-624
30 Jun 221-524
31 Mar 221-524
31 Dec 211-423
30 Sep 211-422
30 Jun 211-423
31 Mar 211-523
31 Dec 201-633
30 Sep 201-835
30 Jun 201-835
31 Mar 201-835
31 Dec 191-734
30 Sep 191-533
30 Jun 191-422
31 Mar 191-322
31 Dec 182-332
30 Sep 182-432
30 Jun 182-542
31 Mar 182-652
31 Dec 172-653
30 Sep 172-652
30 Jun 172-642
31 Mar 172-542
31 Dec 162-542
30 Sep 162-542
30 Jun 162-543
31 Mar 162-543
31 Dec 152-543
30 Sep 151-533
30 Jun 151-432
31 Mar 151-322
31 Dec 141-321
30 Sep 141-221
30 Jun 141-111
31 Mar 141-111
31 Dec 131-111
30 Sep 131-121
30 Jun 132-121

Quality Earnings: TLTF.F is currently unprofitable.

Growing Profit Margin: TLTF.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TLTF.F is unprofitable, but has reduced losses over the past 5 years at a rate of 2% per year.

Accelerating Growth: Unable to compare TLTF.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TLTF.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: TLTF.F has a negative Return on Equity (-239.89%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.